Pfizer CEO stands by company’s performance in response to Starboard activist critique
Pfizer’s CEO Albert Bourla responded to activist investor Starboard Value’s criticisms on Tuesday, as the drugmaker increased its revenue projections for 2024. Bourla defended Pfizer’s management and strategies, stating that the company was already on track for a successful turnaround. He expressed willingness to engage with shareholders, including Starboard, to consider ideas that would benefit … Read more